Top 10 Penny Stocks To Buy in 2017

Page 7 of 11

5. Bioline RX Ltd (NASDAQ:BLRX)

The number of investors long Bioline RX Ltd (NASDAQ:BLRX) jumped by five to nine between January and March. In addition, the total value of these funds’ holdings surged to $31.89 million from $5.95 million. Among them, Mark Lampert’s Biotechnology Value Fund and Hal Mintz’s Sabby Capital initiated stakes containing 17.50 million shares and 3.14 million shares, respectively.

Bioline, an Israel-based biotech company, has a number of products under development and last month announced filing regulatory applications to start a Phase 1b clinical trial of its BL-8040 in combination with Roche’s Tecentriq (atezolizumab) in patients with acute myeloid leukemia.

Likoper/Shutterstock.com

Likoper/Shutterstock.com

Follow Biolinerx Ltd. (NASDAQ:BLRX)

Page 7 of 11